G. Lewin et al. / Tetrahedron Letters 51 (2010) 1145–1148
1147
diosmetin 1
a
OMe
OH
OMe
OH
NO2
BnO
O
HO
O
OH
O
OH
O
10
14
e
b
OMe
OTs
OMe
NO2
HO
O
BnO
O
OTs
OH
O
OH
O
11
13
c
d
OMe
HO
O
OTs
OH
O
12
Scheme 1. Reagents and conditions: (a) KHCO3 1.1 equiv, benzyl chloride 1.2 equiv, DMF, 120 °C, 2 h, 66%; (b) tosyl chloride 5 equiv, pyridine, rt, 1 h, 93%; (c) H2, Pd–C 10%,
DMF, rt, 2 h, 94%; (d) HNO3 1 equiv, CH3COOH, 120 °C, 0.25 h then 60 °C, 1.5 h, 45%; (e) 0.5 N aqueous KOH/MeOH 2/1, 120 °C, 0.5 h, 75%.
150.8 (C-40), 157.8 (C-2 and C-9), 161.5 (C-5), 165.0 (C-7), 180.9 (C-4). HREIMS
References and notes
(+) m/z [M]+ 390.0342 (calcd for C16H10N2O10, 390.0336).
11. Quintin, J.; Lewin, G. Tetrahedron Lett. 2004, 45, 3635–3638.
1. (a) Marder, M.; Viola, H.; Wasowski, C.; Wolfman, C.; Waterman, P. G.; Medina,
12. Quintin, J.; Lewin, G. Tetrahedron Lett. 2005, 46, 4341–4343.
J. H.; Paladini, A. C. Bioorg. Med. Chem. Lett. 1995, 5, 2717–2720; (b) Marder, M.;
13. The position of the nitro group in each isomer was proved by comparative 1H
Zinczuk, J.; Colombo, M. I.; Wasowski, C.; Viola, H.; Wolfman, C.; Medina, J. H.;
NMR experiments (NOESY and COSY). The conclusions were based on: (a) the
Rúveda, E. A.; Paladini, A. C. Bioorg. Med. Chem. Lett. 1997, 7, 2003–2008; (c)
presence of Overhauser effects between H-3 and H-20/H-60 (two NOE
Patent WO 9714414, 1997.
observed for 9b, only one for 9a and 9c); (b) the strong deshielding of H-50
2. (a) Zheng, X.; Meng, W.-D.; Xu, Y.-Y.; Cao, J.-G.; Qing, F.-L. Bioorg. Med. Chem.
signal by the ortho nitro group at 40 for 9b and 60 for 9c. Compound 9a. White
Lett. 2003, 13, 881–884; (b) Cardenas, M.; Marder, M.; Blank, V. C.; Roguin, L. P.
crystals: mp: 231–233 °C (MeOH); 1H NMR (DMSO-d6) d ppm 6.78 (s, 1H, H-
Bioorg. Med. Chem. 2006, 14, 2966–2971.
3), 7.29 (d, J = 8.4 Hz, 1H, H-40), 7.36 (d, J = 7.7 Hz, 1H, H-60), 7.45 (d,
3. Japanese Patent JP 61 68484, 1986.
J = 8.4 Hz, 1H, H-8), 7.50–7.58 (m, 2H, H-6 and H-50), 7.83 (br t, 1H, H-7), 8.05
4. (a) Cushman, M.; Nagarathnam, D.; Burg, L. D.; Geahlen, R. L. J. Med. Chem.
(d, J = 7.9 Hz, 1H, H-5). Compound 9b. White crystals: mp: 238–240 °C
1991, 34, 798–806; (b) Cushman, M.; Zhu, H.; Geahlen, R. L.; Kraker, A. J. J. Med.
(MeOH); 1H NMR (DMSO-d6) d ppm 7.08 (s, 1H, H-3), 7.53 (br t, J = 7.5 Hz,
Chem. 1994, 37, 3353–3362; (c) Quintin, J.; Buisson, D.; Thoret, S.; Cresteil, T.;
1H, H-6), 7.68 (br d, J = 8.7 Hz, 1H, H-60), 7.75–7.79 (m, 2H, H-8 and H-20),
Lewin, G. Bioorg. Med. Chem. Lett. 2009, 19, 3502–3506.
7.86 (br t, 1H, H-7), 8.03 (d, J = 8.7 Hz, 1H, H-50), 8.06 (d, J = 7.9 Hz, 1H, H-5).
5. Gao, H.; Kawabata, J. Bioorg. Med. Chem. 2005, 13, 1661–1671.
Compound 9c. White crystals: mp: 279–282 °C (MeOH); 1H NMR (DMSO-d6) d
6. Larget, R.; Lockhart, B.; Renard, P.; Largeron, M. Bioorg. Med. Chem. Lett. 2000,
ppm 6.63 (s, 1H, H-3), 7.08–7.13 (m, 2H, H-40 and H-20), 7.52 (t, J = 7.7 Hz, 1H,
10, 835–838.
H-6), 7.56 (d, J = 8.5 Hz, 1H, H-8), 7.81 (br t, 1H, H-7), 8.08 (d, J = 7.8 Hz, 1H,
7. Hu, C.-Q.; Chen, K.; Shi, Q.; Kilkuskie, R. E.; Cheng, Y.-C.; Lee, K.-H. J. Nat. Prod.
H-5), 8.16 (d, J = 8.4 Hz, 1H, H-50).
1994, 57, 42–51.
14. Frisch, M. J. et al GAUSSIAN 03; Gaussian: Wallingford, CT, 2004.
8. Quintin, J.; Roullier, C.; Thoret, S.; Lewin, G. Tetrahedron 2006, 62, 4038–
15. Martin, N. H.; Nance, K. H. J. Mol. Graphics Modell. 2002, 21, 51–56.
4051.
16. Quintin, J.; Lewin, G. J. Nat. Prod. 2004, 67, 1624–1627.
9. Mixture of 5a (53%) and 5b (47%). Yellow microcrystalline powder. Compound
17. Compound 12. Yellowish powder: mp: 244–246 °C (MeOH); 1H NMR (DMSO-
5a: 1H NMR ((DMSO-d6)) d ppm 4.00 (s, 3H, OMe-40), 6.19 (d, J = 2.0 Hz, 1H, H-
d6) d ppm flavone moiety: 3.62 (s, 3H, OMe-40), 6.20 (d, J = 2.0 Hz, 1H, H-6),
6), 6.23 (d, J = 2.0 Hz, 1H, H-8), 6.72 (s, H-3), 7.30 (d, J = 8.2 Hz, 1H, H-50), 7.48
6.37 (d, J = 2.0 Hz, 1H, H-8), 6.80 (s, 1H, H-3), 7.21 (d, J = 8.9 Hz, 1H, H-50), 7.54
(d, J = 8.2 Hz, 1H, H-60), 12.64 (s, 1H, OH-5); compound 5b: 3.98 (s, 3H, OMe),
(d, J = 2.0 Hz, 1H, H-20), 8.00 (dd, J = 8.9 and 2.0 Hz, 1H, H-60), 10.9 (br s, 1H, OH-
6.19 (d, J = 2.0 Hz, 1H, H-6), 6.23 (d, J = 2.0 Hz, 1H, H-8), 6.54 (s, H-3), 7.14 (s, H-
7), 12.80 (s, 1H, OH-5); tosyl moiety: 2.45 (s, 3H, Me-400), 7.49 (d, J = 8.9 Hz, 2H,
20), 7.79 (s, H-50), 12.70 (s, 1H, OH-5). HREIMS (+) m/z [M]+ 345.0489 (calcd for
H-300 and 500), 7.75 (d, J = 8.9 Hz, 2H, H-200 and 600). 13C NMR (DMSO-d6) d ppm
C16H11NO8, 345.0485).
flavone moiety: 56.1 (OMe-40), 93.9 (C-8), 98.9 (C-6), 103.7 (C-10), 104.3 (C-3),
10. Compound 6. Beige yellowish powder: mp: 275–277 °C (MeOH); 1H NMR
113.8 (C-50), 121.4 (C-20), 122.9 (C-10), 127.0 (C-60), 145.8 (C-30), 154.3 (C-40),
(DMSO-d6) d ppm 4.05 (s, 3H, OMe-40), 6.26 (d, J = 2.0 Hz, 1H, H-6), 6.33 (d,
157.1 (C-9), 161.4 (C-2), 161.5 (C-5), 164.3 (C-7), 181.6 (C-4); tosyl moiety:
J = 2.0 Hz, 1H, H-8), 6.45 (s, 1H, H-3), 8.00 (s, 1H, H-50), 12.4 (br s, 1H, OH-5).
21.1 (Me), 128.4 (C-200 and 600), 129.9 (C-300 and 500), 131.8 (C-100), 137.7 (C-400).
13C NMR (DMSO-d6) d ppm 57.4 (OMe-40), 94.0 (C-8), 99.5 (C-6), 103.7 (C-10),
EIMS (+) m/z [M]+ 454.
109.7 (C-50), 110.3 (C-3), 114.0 (C-10), 136.7 (C-60), 139.1 (C-20), 146.2 (C-30),